Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Rheumatic disorder
ADR ID BADD_A06692
ADR Hierarchy
10      Immune system disorders
10.02      Immune disorders NEC
10.02.01      Immune and associated conditions NEC
10.02.01.048      Rheumatic disorder
15      Musculoskeletal and connective tissue disorders
15.03      Musculoskeletal and connective tissue disorders NEC
15.03.04      Musculoskeletal and connective tissue pain and discomfort
15.03.04.018      Rheumatic disorder
Description Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement. [MeSH]
MedDRA Code 10072736
MeSH ID D012216; D012213
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Other non-articular rheumatism | Rheumatics | Rheumatism | Rheumatism, unspecified and fibrositis | Rheumatic disorder | Inflammatory rheumatism | Rheumatic Diseases | Disease, Rheumatic | Diseases, Rheumatic | Rheumatic Disease
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00768Enalaprilat0.003039%
BADD_D00774Entecavir0.004903%
BADD_D00945Fluticasone--
BADD_D01119Ibrutinib0.000112%
BADD_D01418Methotrexate0.000250%
BADD_D01535Naratriptan--
BADD_D01536Naratriptan hydrochloride--
BADD_D01567Nilotinib0.000302%
BADD_D01831Prednisolone0.000052%
BADD_D01954Rivaroxaban0.000063%
BADD_D01981Salmeterol--
BADD_D01982Salmeterol xinafoate--
BADD_D02010Sertraline0.000013%
BADD_D02053Sofosbuvir0.000282%
BADD_D02098Sumatriptan--
BADD_D02105Tacrolimus0.000653%
BADD_D02236Tofacitinib0.001350%
BADD_D02380Zanamivir--
BADD_D02407Upadacitinib0.000241%
The 1th Page    1    Total 1 Pages